Zentalis Pharmaceuticals, Inc. short interest in 2020
In 2020, Zentalis Pharmaceuticals, Inc.'s disclosed short interest ran from 6.38% of shares outstanding on 15 Jul 2020 to 7.40% on 31 Dec 2020, a change of +1.02 percentage points. The year's high was 7.40% on 31 Dec 2020 and its low 4.61% on 15 Sep 2020, averaging 5.69% across 12 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.82 days on 14 Aug 2020. Full history: Zentalis Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 6.38% (15 Jul 2020)
- End of year
- 7.40% (31 Dec 2020)
- Change
- +1.02 pp
- High
- 7.40% (31 Dec 2020)
- Low
- 4.61% (15 Sep 2020)
- Average
- 5.69%
- Highest days to cover
- 24.82 (14 Aug 2020)
- SEC filings marked
- 7
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jul 2020 | 6.38% | 19.55 | 10-Q filed, results (8-K) |
| 31 Jul 2020 | 6.71% | 13.69 | results (8-K) |
| 14 Aug 2020 | 6.11% | 24.82 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 5.92% | 24.62 | |
| 15 Sep 2020 | 4.61% | 18.86 | |
| 30 Sep 2020 | 5.26% | 14.61 | |
| 15 Oct 2020 | 5.29% | 17.42 | |
| 30 Oct 2020 | 5.78% | 14.10 | |
| 13 Nov 2020 | 5.28% | 8.51 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 4.91% | 8.29 | |
| 15 Dec 2020 | 4.67% | 5.15 | |
| 31 Dec 2020 | 7.40% | 4.23 |
See also: Zentalis Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.